Co-Diagnostics Stock Is Not a Penny Stock Anymore
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 67
What Trinity Bio Brings to the Fight Against COVID-19
Trinity Biotech released its fiscal fourth-quarter financial results on Tuesday morning, but that wasn’t what propelled the stock afterward.
Will Vivus Be the Next Big Name in Telemedicine?
Vivus shares absolutely exploded on Tuesday after the company announced that it was accelerating the launch of telemedicine and remote monitoring modules.
Why Big Pharmaceutical Stocks May Be the Best Place for Worried Investors Now
Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have been hit hard, and the companies have paid dependable dividends for years.
Who Will Care for People as Thousands of Doctors Close Their Doors?
A physician crisis based on financial issues is about to begin in America and will get worse as the pandemic persists. Many of the doctors who practiced before the spread of COVID-19 will never…
Will Increased COVID-19 Competition Hurt Aytu Biosciences Stock?
There is plenty of competition among companies wanting to sell coronavirus test kits. Aytu Biosciences has placed a bet on its ability to help beat the coronavirus outbreak.
How Much Cash Can Bio-Path Burn?
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Big Pharma Advances on COVID-19
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
American Doctors Will Go Out of Business by the Thousands
An acute shortage of doctors due to financial issues is about to begin in America and will get worse as the pandemic persists.
Dynavax New Vaccine: Are Investors Sick of Coronavirus Vaccine Stocks Yet?
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting oversaturated?
Major Biotechs Get Mixed Message on Short Interest
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Compugen Projected to Rise Over 100% in Key Analyst Report
SunTrust Robinson Humphrey has issued a new Buy rating Compugen, and the firm's target price represents more than 100% in implied upside from the prior close.
How Coronavirus Stocks Are Holding Up
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Is GenMark Diagnostics Underappreciated in the COVID-19 Fight?
GenMark Diagnostics stock has really not made any of the zany exponential gains that have been seen in other coronavirus-related stocks.
Aytu BioScience Soars, Pending Approval of Coronavirus Test
Aytu BioScience was largely unknown until it announced that it had a test for COVID-19. Since then, it has seen a meteoric rise in its common stock price. Does the future look bright?